INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the ...

Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...

Macular degeneration is one of the leading causes of vision loss, affecting millions worldwide, especially those over 60.

The unique challenges, and need for awareness, of age-related macular degeneration (AMD) is now formally recognized in Canada ...

Introduction The eye's macula is impacted by macular degeneration, a neurodegenerative condition. Macular degeneration will cause loss of centr ...

Dry macular degeneration is a common eye disorder among people aged above ... pathway-based therapies for dry AMD, with promising treatments like ALK-001 and LBS-008 in trials, though a ...

Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

New York, United States, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The eye’s macula is impacted by macular ... Nutritional therapy can aid treatment in the early stages of dry macular degeneration. A healthy ...

Dry macular degeneration is a common eye disorder among people aged above ... pathway-based therapies for dry AMD, with promising treatments like ALK-001 and LBS-008 in trials, though a ...

INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the projected therapeutic level, indicating a favorable pharmacokinetic profile and a ...

Dry macular degeneration is a common eye disorder among people aged above 50 years ... focused on developing pathway-based therapies for dry AMD, with promising treatments like ALK-001 and LBS-008 in ...